remifentanil has been researched along with Hematologic Malignancies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akkuş, M; Güneş, D; Ince, IE; Isguven, D; Iyilikci, L; Yilmaz, S | 1 |
| Berkenstadt, H; Keidan, I; Perel, A; Sidi, A | 1 |
2 trial(s) available for remifentanil and Hematologic Malignancies
| Article | Year |
|---|---|
Sedation for short hemato-oncologic invasive procedures in children: comparison of propofol-remifentanil and propofol-fentanyl.
Topics: Adolescent; Analgesics, Opioid; Blood Pressure; Child; Child, Preschool; Conscious Sedation; Female; Fentanyl; Heart Rate; Hematologic Neoplasms; Humans; Hypnotics and Sedatives; Male; Piperidines; Propofol; Prospective Studies; Remifentanil; Respiration | 2013 |
Propofol/remifentanil versus propofol alone for bone marrow aspiration in paediatric haemato-oncological patients.
Topics: Adolescent; Analgesics, Opioid; Anesthesia, Intravenous; Anesthetics, Intravenous; Biopsy, Needle; Bone Marrow; Child; Female; Hematologic Neoplasms; Hemodynamics; Humans; Male; Neoplasms; Piperidines; Propofol; Prospective Studies; Remifentanil; Respiratory Mechanics | 2001 |